Prognostic value of ABO blood group in patients with nonseminomatous testicular cancer who treated with autologous stem cell transplantationBirol Yildiz a,*, Ismail Erturk a, Nuri Karadurmus a, Zeki Gokhan Surmeli a, Ece Esin b, Sukru Ozaydinli a, Bilgin Bahadir Basgoz c, Fikret Arpaci da Department of Medical Oncology, Gulhane Research and Training Hospital, Ankara, Turkey
b Department of Medical Oncology, Dr. Abdurrahman Yurtaslan Oncology Research and Training Hospital, Ankara, Turkey
c Department of Internal Medicine, Gulhane Research and Training Hospital, Ankara, Turkey
d Department of Medical Oncology, Liv Hospital, Ankara, TurkeyDOI: 10.1016/j.jons.2018.01.004 Sayfalar: 70 - 73 1590 Viewed.